Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Malignant Lymphoma

  Free Subscription


1 Am J Surg Pathol
5 Blood
1 Br J Dermatol
4 Br J Haematol
2 Cancer
5 Dtsch Med Wochenschr
1 Eur J Haematol
2 Int J Radiat Oncol Biol Phys
3 Leuk Lymphoma
2 Leukemia
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg Pathol

  1. MARQUES-PIUBELLI ML, Lyapichev KA, Fnu A, Adrada B, et al
    The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance.
    Am J Surg Pathol. 2024;48:e43-e64.
    PubMed         Abstract available


  2. MALINVERNI C, Bernardelli A, Glimelius I, Mirandola M, et al
    Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
    Blood. 2024 May 16:blood.2023023525. doi: 10.1182/blood.2023023525.
    PubMed         Abstract available

  3. MRD and EFS in pediatric T-lymphoblastic lymphoma.
    Blood. 2024;143:2111.

  4. Silva A, Almeida ARM, Cachucho A, et al. Overexpression of wild-type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia/lymphoma. Blood. 2021;138(12):1040-1052.
    Blood. 2024;143:2108-2110.

  5. YUAN CT, Ma WL
    Transformed mantle cell lymphoma with additional triple-hit genotypes can be resistant to a Bruton tyrosine kinase inhibitor.
    Blood. 2024;143:2106.

    MRD: also for T-lymphoblastic lymphoma.
    Blood. 2024;143:2017-2019.

    Br J Dermatol

  7. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.

    Br J Haematol

    Considerations for anti-PD1-based first-line treatment of Hodgkin lymphoma.
    Br J Haematol. 2024 May 16. doi: 10.1111/bjh.19534.
    PubMed         Abstract available

  9. SOUMERAI JD, Diefenbach CS, Jagadeesh D, Asch A, et al
    Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
    Br J Haematol. 2024;204:1762-1770.
    PubMed         Abstract available

  10. BRILLEMBOURG H, Martinez-Cibrian N, Bachiller M, Alserawan L, et al
    The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B-cell malignancies.
    Br J Haematol. 2024;204:1649-1659.
    PubMed         Abstract available

  11. FARDELLA E, Zanirato G, Magni M, Caldarelli N, et al
    Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas.
    Br J Haematol. 2024;204:1752-1756.
    PubMed         Abstract available


  12. HSU YT, Wu SJ, Kao HW, Hsiao SY, et al
    Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan.
    Cancer. 2024;130:1972-1981.
    PubMed         Abstract available

  13. SEDETA E, Jemal A, Nisotel L, Sung H, et al
    Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
    Cancer. 2024 Jan 20. doi: 10.1002/cncr.35214.
    PubMed         Abstract available

    Dtsch Med Wochenschr

    Dtsch Med Wochenschr. 2024;149:601.

  15. HARTMANN S, Rudelius M
    [New classifications of malignant lymphomas - What changes are relevant for practice?].
    Dtsch Med Wochenschr. 2024;149:613-620.
    PubMed         Abstract available

  16. HELLMUTH JC, Koch R, Weigert O
    [Targeted therapies in the management of malignant lymphoma - is the end of conventional chemotherapy near?].
    Dtsch Med Wochenschr. 2024;149:621-629.
    PubMed         Abstract available

  17. BUCKLEIN V, von Tresckow B, Subklewe M
    [T-cell recruiting immunotherapies in B-cell lymphoma - the future backbone for all therapy lines?].
    Dtsch Med Wochenschr. 2024;149:630-637.
    PubMed         Abstract available

  18. ALIG S, Pott C, Chapuy B
    [Malignant lymphomas - quo vadis? - What developments await us in diagnostics and therapy?].
    Dtsch Med Wochenschr. 2024;149:638-645.
    PubMed         Abstract available

    Eur J Haematol

  19. VELA-OJEDA J, Olivas-Bejarano AC, Montiel-Cervantes LA, Rosales-Cruz E, et al
    Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma.
    Eur J Haematol. 2024 May 14. doi: 10.1111/ejh.14230.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  20. COOPER BT, Mayo CS, Milano MT, Olch AJ, et al
    Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:494-506.
    PubMed         Abstract available

  21. LO AC, Ronckers C, Aznar MC, Avanzo M, et al
    Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:549-559.
    PubMed         Abstract available

    Leuk Lymphoma

  22. DI M, Su CT, Cowan AJ, Gopal AK, et al
    Mitigating time toxicity in lymphoma and multiple myeloma.
    Leuk Lymphoma. 2024 May 15:1-12. doi: 10.1080/10428194.2024.2352086.
    PubMed         Abstract available

  23. DESPAS F, Chaouki M, de Barros S, Bonneau B, et al
    Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure.
    Leuk Lymphoma. 2024 May 15:1-3. doi: 10.1080/10428194.2024.2353330.

  24. CHERIAN S, Modelevsky L, Reiner AS, Grommes C, et al
    Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center.
    Leuk Lymphoma. 2024 May 14:1-4. doi: 10.1080/10428194.2024.2343778.


  25. LIANG JH, Wu YF, Shen HR, Li Y, et al
    Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma.
    Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02279.
    PubMed         Abstract available

  26. WANG TP, Ahn KW, Shadman M, Kaur M, et al
    Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
    Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02242.
    PubMed         Abstract available

    Oncol Rep

  27. GUO Z, Wang C, Shi X, Wang Z, et al
    Advances in proteomics in diffuse large B?cell lymphoma (Review).
    Oncol Rep. 2024;51:87.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.